Sonova Holding AG (SONVY)
USD 65.17
(0.11%)
USD 65.17
(0.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.79 Billion CHF | -1.11% |
| 2023 | 1.81 Billion CHF | 22.27% |
| 2022 | 1.48 Billion CHF | -19.06% |
| 2021 | 1.83 Billion CHF | 73.28% |
| 2020 | 1.05 Billion CHF | 73.55% |
| 2019 | 609.8 Million CHF | -19.7% |
| 2018 | 759.4 Million CHF | -2.68% |
| 2017 | 780.31 Million CHF | 3492.61% |
| 2016 | 21.72 Million CHF | 14380.0% |
| 2015 | 150 Thousand CHF | -99.81% |
| 2014 | 79.99 Million CHF | -65.07% |
| 2013 | 228.99 Million CHF | -11.17% |
| 2012 | 257.8 Million CHF | -3.84% |
| 2011 | 268.09 Million CHF | -42.69% |
| 2010 | 467.76 Million CHF | 44154.4% |
| 2009 | 1.05 Million CHF | 46.81% |
| 2008 | 720 Thousand CHF | 1025.0% |
| 2007 | 64 Thousand CHF | -99.5% |
| 2006 | 12.72 Million CHF | -85.93% |
| 2005 | 90.43 Million CHF | -17.46% |
| 2004 | 109.56 Million CHF | -18.57% |
| 2003 | 134.54 Million CHF | -18.78% |
| 2002 | 165.65 Million CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 1.79 Billion CHF | -6.75% |
| 2024 FY | 1.79 Billion CHF | -1.11% |
| 2024 Q2 | 1.92 Billion CHF | 6.04% |
| 2023 FY | 1.81 Billion CHF | 22.27% |
| 2023 Q2 | 1.77 Billion CHF | 19.91% |
| 2023 Q4 | 1.81 Billion CHF | 1.97% |
| 2022 FY | 1.48 Billion CHF | -19.06% |
| 2022 Q2 | 1.86 Billion CHF | 1.84% |
| 2022 Q4 | 1.48 Billion CHF | -20.52% |
| 2021 FY | 1.83 Billion CHF | 73.28% |
| 2021 Q4 | 1.83 Billion CHF | -1.94% |
| 2021 Q2 | 1.87 Billion CHF | 76.71% |
| 2020 Q4 | 1.05 Billion CHF | 5.97% |
| 2020 Q2 | 998.7 Million CHF | 63.78% |
| 2020 FY | 1.05 Billion CHF | 73.55% |
| 2019 Q4 | 609.8 Million CHF | -21.32% |
| 2019 Q2 | 775.01 Million CHF | 2.06% |
| 2019 FY | 609.8 Million CHF | -19.7% |
| 2018 Q2 | 785.79 Million CHF | 3.49% |
| 2018 FY | 759.4 Million CHF | -2.68% |
| 2018 Q4 | 759.4 Million CHF | -3.36% |
| 2017 Q2 | 847.73 Million CHF | 580539.73% |
| 2017 Q4 | 759.29 Million CHF | -10.43% |
| 2017 FY | 780.31 Million CHF | 3492.61% |
| 2016 FY | 21.72 Million CHF | 14380.0% |
| 2016 Q4 | 146 Thousand CHF | -99.28% |
| 2016 Q2 | 20.28 Million CHF | 13422.67% |
| 2015 Q2 | 12.66 Million CHF | -84.17% |
| 2015 FY | 150 Thousand CHF | -99.81% |
| 2015 Q4 | 150 Thousand CHF | -98.82% |
| 2014 Q4 | 79.99 Million CHF | -67.21% |
| 2014 Q2 | 243.94 Million CHF | 6.53% |
| 2014 FY | 79.99 Million CHF | -65.07% |
| 2013 Q2 | 66 Thousand CHF | -99.97% |
| 2013 Q4 | 228.99 Million CHF | 346865.15% |
| 2013 FY | 228.99 Million CHF | -11.17% |
| 2012 Q4 | 257.8 Million CHF | 1149.18% |
| 2012 FY | 257.8 Million CHF | -3.84% |
| 2012 Q2 | 20.63 Million CHF | -92.3% |
| 2011 FY | 268.09 Million CHF | -42.69% |
| 2011 Q4 | 268.09 Million CHF | 237.02% |
| 2011 Q2 | 79.54 Million CHF | -82.99% |
| 2010 FY | 467.76 Million CHF | 44154.4% |
| 2010 Q4 | 467.76 Million CHF | 0.0% |
| 2009 FY | 1.05 Million CHF | 46.81% |
| 2008 FY | 720 Thousand CHF | 1025.0% |
| 2007 FY | 64 Thousand CHF | -99.5% |
| 2006 FY | 12.72 Million CHF | -85.93% |
| 2005 FY | 90.43 Million CHF | -17.46% |
| 2004 FY | 109.56 Million CHF | -18.57% |
| 2003 FY | 134.54 Million CHF | -18.78% |
| 2002 FY | 165.65 Million CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -399158.704% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -2990900.0% |
| Össur hf. | 467.73 Million USD | -283.68% |
| QHSLab, Inc. | 1.78 Million USD | -100632.395% |
| Wellstar International, Inc. | 51.36 Million USD | -3393.687% |
| Össur hf. | 467.73 Million USD | -283.68% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | -341911.629% |
| Aurora Spine Corporation | 2.67 Million USD | -67099.389% |
| BrainsWay Ltd. | 471 Thousand USD | -380919.108% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | -12000.136% |
| Hamilton Thorne Ltd. | 27.81 Million USD | -6352.879% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -361423.694% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -1007456.958% |
| Zecotek Photonics Inc. | 3.22 Million USD | -55600.779% |
| Avitar, Inc. | 5.26 Million USD | -33984.007% |
| Nanomix Corporation | 11.4 Million USD | -15633.457% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -34292.31% |
| Theraclion SA | 1.95 Million EUR | -91896.047% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | -100295.349% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -105555.072% |
| Lombard Medical, Inc. | 32.29 Million USD | -5457.414% |
| ALR Technologies Inc. | 19.26 Million USD | -9215.742% |
| Stratec SE | 156.16 Million USD | -1049.166% |
| Vycor Medical, Inc. | 1.11 Million USD | -161539.562% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -857390.981% |
| MicroPort Scientific Corporation | 1.69 Billion USD | -5.671% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1344068204.374% |
| NewCardio, Inc. | 3 Million USD | -59720.0% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -87101.209% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -284234.959% |
| Odyssey Group International, Inc. | 2.14 Million USD | -83577.599% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -267750.746% |
| Wellness Center USA, Inc. | 4.04 Million USD | -44298.999% |
| SANUWAVE Health, Inc. | 31.94 Million USD | -5517.956% |
| IR-Med Inc. | 161 Thousand USD | -1114558.385% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -930255.532% |
| Polarean Imaging plc | 216.38 Thousand USD | -829255.085% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | -56489.566% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -1794500.0% |
| Capital Group Holdings, Inc. | 4944.00 USD | -36298443.689% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -224320.659% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -790465.722% |
| Urologix, Inc. | 5.33 Million USD | -33550.853% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -46748.091% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -42474.401% |
| SS Innovations International, Inc. | 8.21 Million USD | -21736.511% |
| Qualis Innovations, Inc. | 9102.00 USD | -19716445.814% |
| Smith & Nephew plc | 3.07 Billion USD | 41.727% |
| NIOX Group Plc | 1.4 Million USD | -128058.252% |
| Fuse Medical, Inc. | 1.99 Million USD | -89915.258% |
| Broncus Holding Corporation | 2.35 Million USD | -76124.537% |
| Brain Scientific Inc. | 2.86 Million USD | -62571.884% |
| Pressure BioSciences, Inc. | 22.75 Million USD | -7785.452% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -4437366.001% |